Exchange: TSX·Updated 03:32 PM EDT

SZLS.TSX StageZero Life Sciences Ltd

$0.001
$0.00
(0.00%)
Today
Mkt Cap$123,600.00
Vol208.00

About SZLS.TSX

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.
0

Extremely Bearish Sentiment

How do you feel about SZLS.TSX?

Advertisement|Remove ads.